rs56132472

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_004304.5(ALK):​c.4338C>T​(p.Thr1446Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.109 in 1,598,386 control chromosomes in the GnomAD database, including 10,721 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. T1446T) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.10 ( 972 hom., cov: 32)
Exomes 𝑓: 0.11 ( 9749 hom. )

Consequence

ALK
NM_004304.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: 1.22

Publications

20 publications found
Variant links:
Genes affected
ALK (HGNC:427): (ALK receptor tyrosine kinase) This gene encodes a receptor tyrosine kinase, which belongs to the insulin receptor superfamily. This protein comprises an extracellular domain, an hydrophobic stretch corresponding to a single pass transmembrane region, and an intracellular kinase domain. It plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. This gene has been found to be rearranged, mutated, or amplified in a series of tumours including anaplastic large cell lymphomas, neuroblastoma, and non-small cell lung cancer. The chromosomal rearrangements are the most common genetic alterations in this gene, which result in creation of multiple fusion genes in tumourigenesis, including ALK (chromosome 2)/EML4 (chromosome 2), ALK/RANBP2 (chromosome 2), ALK/ATIC (chromosome 2), ALK/TFG (chromosome 3), ALK/NPM1 (chromosome 5), ALK/SQSTM1 (chromosome 5), ALK/KIF5B (chromosome 10), ALK/CLTC (chromosome 17), ALK/TPM4 (chromosome 19), and ALK/MSN (chromosome X).[provided by RefSeq, Jan 2011]
CLIP4 (HGNC:26108): (CAP-Gly domain containing linker protein family member 4) Predicted to enable microtubule plus-end binding activity. Predicted to be involved in cytoplasmic microtubule organization. Located in intracellular membrane-bounded organelle. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 2-29193749-G-A is Benign according to our data. Variant chr2-29193749-G-A is described in ClinVar as Benign. ClinVar VariationId is 259273.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.22 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.119 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004304.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALK
NM_004304.5
MANE Select
c.4338C>Tp.Thr1446Thr
synonymous
Exon 29 of 29NP_004295.2
ALK
NM_001353765.2
c.1134C>Tp.Thr378Thr
synonymous
Exon 10 of 10NP_001340694.1A0A0K2YUJ3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ALK
ENST00000389048.8
TSL:1 MANE Select
c.4338C>Tp.Thr1446Thr
synonymous
Exon 29 of 29ENSP00000373700.3Q9UM73
ALK
ENST00000638605.1
TSL:1
n.1215C>T
non_coding_transcript_exon
Exon 11 of 11
ALK
ENST00000618119.4
TSL:5
c.3207C>Tp.Thr1069Thr
synonymous
Exon 28 of 28ENSP00000482733.1A0A087WZL3

Frequencies

GnomAD3 genomes
AF:
0.104
AC:
15833
AN:
152102
Hom.:
973
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0871
Gnomad AMI
AF:
0.148
Gnomad AMR
AF:
0.0827
Gnomad ASJ
AF:
0.117
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0308
Gnomad FIN
AF:
0.164
Gnomad MID
AF:
0.0949
Gnomad NFE
AF:
0.122
Gnomad OTH
AF:
0.108
GnomAD2 exomes
AF:
0.0928
AC:
22254
AN:
239714
AF XY:
0.0933
show subpopulations
Gnomad AFR exome
AF:
0.0882
Gnomad AMR exome
AF:
0.0526
Gnomad ASJ exome
AF:
0.119
Gnomad EAS exome
AF:
0.000165
Gnomad FIN exome
AF:
0.162
Gnomad NFE exome
AF:
0.119
Gnomad OTH exome
AF:
0.106
GnomAD4 exome
AF:
0.110
AC:
158689
AN:
1446166
Hom.:
9749
Cov.:
36
AF XY:
0.108
AC XY:
77576
AN XY:
717514
show subpopulations
African (AFR)
AF:
0.0862
AC:
2837
AN:
32908
American (AMR)
AF:
0.0574
AC:
2488
AN:
43334
Ashkenazi Jewish (ASJ)
AF:
0.115
AC:
2885
AN:
25058
East Asian (EAS)
AF:
0.0000759
AC:
3
AN:
39512
South Asian (SAS)
AF:
0.0404
AC:
3390
AN:
84004
European-Finnish (FIN)
AF:
0.159
AC:
8364
AN:
52738
Middle Eastern (MID)
AF:
0.102
AC:
580
AN:
5674
European-Non Finnish (NFE)
AF:
0.120
AC:
132138
AN:
1103286
Other (OTH)
AF:
0.101
AC:
6004
AN:
59652
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.480
Heterozygous variant carriers
0
9073
18145
27218
36290
45363
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4610
9220
13830
18440
23050
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.104
AC:
15833
AN:
152220
Hom.:
972
Cov.:
32
AF XY:
0.104
AC XY:
7754
AN XY:
74416
show subpopulations
African (AFR)
AF:
0.0869
AC:
3612
AN:
41542
American (AMR)
AF:
0.0826
AC:
1264
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.117
AC:
407
AN:
3468
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5168
South Asian (SAS)
AF:
0.0309
AC:
149
AN:
4826
European-Finnish (FIN)
AF:
0.164
AC:
1739
AN:
10588
Middle Eastern (MID)
AF:
0.0952
AC:
28
AN:
294
European-Non Finnish (NFE)
AF:
0.122
AC:
8273
AN:
68004
Other (OTH)
AF:
0.106
AC:
225
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
734
1468
2203
2937
3671
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
176
352
528
704
880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.109
Hom.:
648
Bravo
AF:
0.0978
Asia WGS
AF:
0.0160
AC:
59
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
Neuroblastoma, susceptibility to, 3 (3)
-
-
2
not provided (2)
-
-
2
not specified (2)
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
-
1
Squamous cell lung carcinoma (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
0.75
DANN
Benign
0.68
PhyloP100
1.2
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56132472; hg19: chr2-29416615; COSMIC: COSV66564612; COSMIC: COSV66564612; API